Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study

NCT06814548 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer, Gastroesophageal Junction Cancer
Immune Checkpoint Inhibitors (ICIs)
Second-line
Retreatment

Interventions

OTHER: ICIs(Immune checkpoint inhibitors)

Sponsor

Yongxu Jia